from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3876/espI

LFCtreatmentdescriptionclass of inhibitor

-1.726

Amikacinug/mL Amikacintranslation

-1.120

Cap5-10ug/mL Capreomycintranslation

-2.285

Rox10-50 ug/mL Roxithromycintranslation

0.076

SM2-5 ug/mL Streptomycintranslation

-0.946

Tet5-10 ug/mL Tetracyclinetranslation

-1.260

Rif0.2-5ug/mL Rifampicintranscription

-1.235

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.812

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.345

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.917

CPZ10-50 ug/mL Chlorpromazinerespiration

1.186

Clofazimine10-13 ug/mL Clofaziminerespiration

0.480

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.475

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.271

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.109

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.504

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.965

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.718

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.096

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.381

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.879

KCN5-20 ug/mL Potassium cyaniderespiration

1.489

NaN30.2-2 mM Sodium aziderespiration

-0.476

Nigericin50 uM Nigericinrespiration

0.170

TRC10-150 ug/mL Triclosanrespiration

1.084

TRZ10-25 ug/mL Thioridazinerespiration

-0.301

Valinomycin0.5-10 uM Valinomycinrespiration

0.321

ZnSO42 mM ZnSO4respiration

0.592

menadione6-10 ug/mL Menadionerespiration

0.087

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.310

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.096

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.146

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.277

NRP_1Non-replicating persistence stage 1dosRassociated

0.961

Amp0.2mg/mL AmpicillincellWall

0.005

Cephalexin20-100 ug/mL CephalexincellWall

-0.153

Cerulenin0.32-5 ug/mL CerulenincellWall

0.344

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.185

EMB10-20 ug/mL EthambutolcellWall

0.636

Eta12-40 ug/mL EthionamidecellWall

0.149

INH0.2-0.4 ug/mL IsoniazidcellWall

0.563

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.133

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.884

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.259

BZA0.12 mg/mL BenzamidearomaticAmides

0.059

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.006

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.939

H2O24 mM hydrogen peroxideDNAdamaging

-0.834

Levo10 ug/mL LevofloxacinDNAdamaging

-0.196

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.304

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.903

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.767

UVUV-irradiationDNAdamaging

0.215

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.314

Antimycin12.5-50 ug/mL Antimycin A?

-0.557

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.571

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.027

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.348

PA8240.2-2 ug/mL PA-824?

0.527

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.211

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.423

Verapamil50 uM Verapamil?

-0.735

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.530

methoxatin10-20 ug/mL Methoxatin?